PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

- Solid Tumors
- Withdrawn

Study Title: Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Teva Identifier: NEUGR-005

ClinicalTrials.gov Identifier: NCT01940601

Study Status: Withdrawn

Trial Condition(s): Solid Tumors

Interventions: Drug: Balugrastim | Drug: Filgrastim

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 2 Years to 17 Years

Trial Duration: 09/01/2014 - 12/01/2015

Phase: Phase 2

Study Type

Interventional